A larger sample size is needed to reliably assess the effect of metreleptin therapy on mortality risk in the GL subgroup, where a nonsignificant trend towards lower mortality was observed, as well as in subgroups of specific GL and PL subtypes.
← all excerpts
Effect of Leptin Therapy on Survival in Generalized and Partial Lipodystrophy: A Matched Cohort Analysis.
1
—
—